Psicobiología y Metodología en Ciencias del Comportamiento
Departamento
![Foto de Psicobiología y Metodología en Ciencias del Comportamiento](/img/uploaded/34E8D2B7DF4FC970D6FD97E5D96CDC4B.jpg)
![Foto de Instituto de Química Médica](/img/noimage_org.png)
Instituto de Química Médica
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Química Médica (6)
2014
-
Combining rimonabant and fentanyl in a single entity: Preparation and pharmacological results
Drug Design, Development and Therapy, Vol. 8, pp. 263-277
2013
-
Description of a bivalent cannabinoid ligand with hypophagic properties
Archiv der Pharmazie, Vol. 346, Núm. 3, pp. 171-179
-
Ghrelin-Induced Orexigenic Effect in Rats Depends on the Metabolic Status and Is Counteracted by Peripheral CB1 Receptor Antagonism
PLoS ONE, Vol. 8, Núm. 4
-
Novel antiobesity agents: Synthesis and pharmacological evaluation of analogues of Rimonabant and of LH21
Bioorganic and Medicinal Chemistry, Vol. 21, Núm. 7, pp. 1708-1716
2012
-
Chromenopyrazoles: Non-psychoactive and Selective CB 1 Cannabinoid Agonists with Peripheral Antinociceptive Properties
ChemMedChem, Vol. 7, Núm. 3, pp. 452-463
2010
-
Synthesis and pharmacological evaluation of new (E)- and (Z)-3-aryl-4-styryl-1H-pyrazoles as potential cannabinoid ligands
Arkivoc, Vol. 2010, Núm. 10, pp. 226-247